PER 0.00% 8.0¢ percheron therapeutics limited

DMD results, page-13

  1. 334 Posts.
    lightbulb Created with Sketch. 123
    Obviously they are different drugs Gassy, all I'm saying is that Catabasis showed similar early success to ANP in a non-Placebo controlled study, compared to natural history of disease progression, targeting logical biomarkers, AND positive MRI data...and in the end all it meant was clinical failure.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $99.06K 1.226M

Buyers (Bids)

No. Vol. Price($)
1 3500 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 40625 1
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.